Bioxcel Therapeutics Stock Price on October 15, 2024
| BTAI Stock | USD 0.47 0.04 7.84% |
Below is the normalized historical share price chart for BioXcel Therapeutics extending back to March 08, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioXcel Therapeutics stands at 0.47, as last reported on the 26th of November, with the highest price reaching 0.50 and the lowest price hitting 0.45 during the day.
If you're considering investing in BioXcel Stock, it is important to understand the factors that can impact its price. BioXcel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0318, which signifies that the company had a -0.0318% return per unit of risk over the last 3 months. BioXcel Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioXcel Therapeutics' Mean Deviation of 4.54, standard deviation of 6.23, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide.
As of now, BioXcel Therapeutics' Other Stockholder Equity is increasing as compared to previous years. The BioXcel Therapeutics' current Liabilities And Stockholders Equity is estimated to increase to about 112.8 M, while Total Stockholder Equity is forecasted to increase to (53.7 M). . The current Price To Sales Ratio is estimated to decrease to 59.16. The current Price Earnings Ratio is estimated to decrease to -0.5. BioXcel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of March 2018 | 200 Day MA 1.5465 | 50 Day MA 0.5995 | Beta 0.289 |
BioXcel |
Sharpe Ratio = -0.0318
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BTAI |
Estimated Market Risk
| 6.24 actual daily | 55 55% of assets are less volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioXcel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioXcel Therapeutics by adding BioXcel Therapeutics to a well-diversified portfolio.
Price Book 3.9656 | Enterprise Value Ebitda (0.75) | Price Sales 9.0549 | Shares Float 29.7 M | Wall Street Target Price 4.2 |
BioXcel Therapeutics Main Headline on 15th of October 2024
BioXcel Therapeutics Announces U.S. Department of Defense Gr... by finance.yahoo.com
Phase 2a efficacy and safety trial enrollment initiation expected in H1 2025 40 million Americans go to emergency department annually after a traumatic experience 1 Second externally funded stress-related trial for BXCL501 NEW HAVEN, Conn., Oct. 15, 2024 -- BioXcel Therapeutics, Inc. , a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced a collaboration with the University of North Carol
BioXcel Therapeutics Valuation on October 15, 2024
It is possible to determine the worth of BioXcel Therapeutics on a given historical date. On October 15, 2024 BioXcel was worth 0.53 at the beginning of the trading date compared to the closed value of 0.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioXcel Therapeutics stock. Still, in general, we apply an absolute valuation method to find BioXcel Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioXcel Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioXcel Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.53 | 0.55 | 0.52 | 0.54 | 357,746 | |
10/15/2024 | 0.53 | 0.59 | 0.53 | 0.57 | 455,779 |
| 0.57 | 0.59 | 0.57 | 0.58 | 243,082 |
| Backtest BioXcel Therapeutics | | | BioXcel Therapeutics History | | | BioXcel Therapeutics Valuation | Previous | Next |
BioXcel Therapeutics Trading Date Momentum on October 15, 2024
| On October 16 2024 BioXcel Therapeutics was traded for 0.58 at the closing time. The top price for the day was 0.59 and the lowest listed price was 0.57 . The trading volume for the day was 243.1 K. The trading history from October 16, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 1.75% . The overall trading delta against the current closing price is 5.26% . |
BioXcel Therapeutics Fundamentals Correlations and Trends
By evaluating BioXcel Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioXcel Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioXcel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BioXcel Therapeutics Stock history
BioXcel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioXcel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioXcel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioXcel Therapeutics stock prices may prove useful in developing a viable investing in BioXcel Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.1 M | 21.5 M | |
| Net Loss | -149.2 M | -141.7 M |
BioXcel Therapeutics Quarterly Net Working Capital |
|
BioXcel Therapeutics Stock Technical Analysis
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BioXcel Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
BioXcel Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BioXcel Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how BioXcel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioXcel Therapeutics shares will generate the highest return on investment. By undertsting and applying BioXcel Therapeutics stock market strength indicators, traders can identify BioXcel Therapeutics entry and exit signals to maximize returns
BioXcel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioXcel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of BioXcel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioXcel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (0.08) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |